These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2159733)

  • 1. Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction.
    Howarth DM; Sampson DC; Hawker FH; Young A
    Anaesth Intensive Care; 1990 Feb; 18(1):45-52. PubMed ID: 2159733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levels of ACTH and endogenous-digitalis-like substances in human blood].
    Horký K; Schreiber V; Dvoráková J
    Sb Lek; 1989 Sep; 91(8-9):265-73. PubMed ID: 2562773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin-like immunoreactive substance in pregnancy.
    González AR; Phelps SJ; Cochran EB; Sibai BM
    Am J Obstet Gynecol; 1987 Sep; 157(3):660-4. PubMed ID: 2820228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-like immunoreactive substances in severe acute liver disease due to viral hepatitis and paracetamol overdose.
    Yang SS; Hughes RD; Williams R
    Hepatology; 1988; 8(1):93-7. PubMed ID: 2828215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
    Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
    Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of endogenous digoxin-like substances on the interpretation of high concentrations of digoxin in children.
    Stone J; Bentur Y; Zalstein E; Soldin S; Giesbrecht E; Koren G
    J Pediatr; 1990 Aug; 117(2 Pt 1):321-5. PubMed ID: 2166153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria for identifying endogenous compounds as digoxin-like immunoreactive factors in humans.
    Lau BW; Valdes R
    Clin Chim Acta; 1988 Jun; 175(1):67-77. PubMed ID: 2844442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
    Matheke ML; Valdes R
    Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of digoxin-like immunoreactive factor (DLIF) for intensive care medicine].
    Simon HB; Behrendt W; Stein T
    Anasth Intensivther Notfallmed; 1990 Jun; 25(3):235-6. PubMed ID: 2168132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin-like immunoreactive substance in renal transplant patients.
    Schrader BJ; Maddux MS; Veremis SA; Mozes MF; Maturen A; Bauman JL
    J Clin Pharmacol; 1991 Dec; 31(12):1126-31. PubMed ID: 1662232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin-like substance(s) interfere(s) with serum estimations of the drug in cirrhotic patients.
    Nikou GC; Vyssoulis GP; Venetikou MS; Karga HI; Karoutsos KA; Toutouzas PK
    J Clin Gastroenterol; 1989 Aug; 11(4):430-3. PubMed ID: 2547866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile salts as endogenous digitalis like factors.
    Vasdev SC; Longerich LL; Ittel TH; Johnson E; Barrowman JA; Gault MH
    Clin Invest Med; 1986; 9(3):201-8. PubMed ID: 3019598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
    Li J; Wu Z; Xu J; Zhou Y; Chu X
    Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-like immunoreactive substances in urine and serum from preterm and term infants: relationship to renal excretion of sodium.
    Ebara H; Suzuki S; Nagashima K; Shimano S; Kuroume T
    J Pediatr; 1986 May; 108(5 Pt 1):760-2. PubMed ID: 3009770
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endogenous digitalis-like substance and Na-K-ATPase inhibitor in cardiovascular and renal disease].
    Okamoto S
    Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):39-50. PubMed ID: 2837414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and comparison of the TDxII, Stratus, and OPUS digoxin assays.
    Dodds HM; Norris RL; Johnson AG; Pond SM
    Ther Drug Monit; 1995 Feb; 17(1):68-74. PubMed ID: 7725380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin-like-immunoreactive substance: non-specific interference or a new hormone?
    Clerico A; Ghione S; Balzan S; Del Chicca MG
    J Nucl Med Allied Sci; 1984; 28(4):297-301. PubMed ID: 6100187
    [No Abstract]   [Full Text] [Related]  

  • 19. Endogenous digitalis-like factors.
    Graves SW
    Crit Rev Clin Lab Sci; 1986; 23(3):177-200. PubMed ID: 3015491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Observations on serum digoxin-like immunoreactive substances in patients with cor-pulmonale].
    Shi YS; Liu JH; Yu XZ
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):229-31. PubMed ID: 8156846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.